WebTrethera has 5 employees at their 1 location and $7.4 m in total funding,. See insights on Trethera including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Advanced. Products. ... biotech. drug … WebTrethera is a biotechnology company that discovers and develops small molecules that control DNA replication and integrity.This approach is designed to overcome the …
Trethera Corporation Company Profile, Financial and Strategic …
WebTrethera Receives $1.6 Million National Eye Institute Grant for Continued Advancement of TRE-515 Optic Neuritis Program WebTrethera General Information. Description. Developer of novel drugs targeting nucleotide metabolism designed to provide treatment of cancer and autoimmune diseases. The company's drugs are deoxycytidine kinase inhibitor that improves bioavailability and demonstrates anti-tumor activity in combination therapies, enabling patients to avail of … butters south park lines
Trethera and UCLA Publish Data Demonstrating TRE-515 Ability to …
WebBioTether Sciences™, Inc is a biotechnology company devoted to the development of solutions to unmet medical problems. We are actively engaged in developing novel … WebWelcome to my profile. I'm Christelle and I have a portfolio career working as a qualified Coach, Mentor, and Marketing & Communications specialist. I am also a trained Mental … WebTrethera's innovative approach to targeting nucleotide metabolism led to the development of TRE-515, an orally administered capsule twice designated by the FDA as an Orphan Drug. TRE-515 is a first-in-class clinical stage drug that inhibits deoxycytidine kinase (dCK), the rate-limiting enzyme in the nucleoside salvage pathway, one of two biosynthetic pathways … cedar grove mobile home park foley al